Dr. Daniel Soffer, MD

Internal Medicine Media, PA Male
NPI: 1205863198
Total Payments
$61,441
2024 Payments
$10,665
Companies
21
Transactions
85
Medicare Patients
6,113
Medicare Billing
$351,729

Payment Breakdown by Category

Consulting$41,743 (67.9%)
Research$8,750 (14.2%)
Other$5,650 (9.2%)
Food & Beverage$4,215 (6.9%)
Travel$1,082 (1.8%)
Education$1.66 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $41,743 14 67.9%
Unspecified $8,750 1 14.2%
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $5,000 1 8.1%
Food and Beverage $4,215 59 6.9%
Travel and Lodging $1,082 6 1.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $650.00 2 1.1%
Education $1.66 2 0.0%

Payments by Type

General
$52,691
84 transactions
Research
$8,750
1 transactions

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $20,368 8 $0 (2024)
Regeneron Pharmaceuticals, Inc. $18,566 20 $0 (2024)
Kaneka Pharma America LLC $5,112 2 $0 (2020)
Amryt Pharma Holdings Ltd $4,230 1 $0 (2023)
Amgen Inc. $4,220 13 $0 (2024)
Akcea Therapeutics, Inc. $2,120 1 $0 (2021)
SANOFI-AVENTIS U.S. LLC $1,956 2 $0 (2018)
HEARTFLOW, INC. $1,698 4 $0 (2024)
Medicure Pharma Inc. $1,256 4 $0 (2019)
Regeneron Healthcare Solutions, Inc. $1,095 14 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $10,665 16 Regeneron Pharmaceuticals, Inc. ($8,253)
2023 $9,934 7 NOVARTIS PHARMACEUTICALS CORPORATION ($5,469)
2022 $5,229 6 Novartis Pharmaceuticals Corporation ($4,911)
2021 $12,035 4 Novartis Pharmaceuticals Corporation ($9,832)
2020 $5,121 2 Kaneka Pharma America LLC ($5,000)
2019 $4,558 16 Amgen Inc. ($3,347)
2018 $13,393 25 Regeneron Pharmaceuticals, Inc. ($10,185)
2017 $504.65 9 Aegerion Pharmaceuticals, Inc. ($181.16)

All Payment Transactions

85 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/04/2024 HEARTFLOW, INC. FFRct (Device) Food and Beverage Cash or cash equivalent $33.50 General
Category: Coronary
10/25/2024 Regeneron Pharmaceuticals, Inc. — Consulting Fee Cash or cash equivalent $5,406.00 General
10/25/2024 Regeneron Pharmaceuticals, Inc. — Consulting Fee Cash or cash equivalent $1,802.00 General
10/25/2024 Regeneron Pharmaceuticals, Inc. — Consulting Fee Cash or cash equivalent $901.00 General
09/04/2024 Regeneron Pharmaceuticals, Inc. EVKEEZA (Biological) Food and Beverage In-kind items and services $81.58 General
Category: CARDIOVASCULAR AND METABOLISM
09/04/2024 Regeneron Pharmaceuticals, Inc. EVKEEZA (Biological) Food and Beverage In-kind items and services $62.91 General
Category: CARDIOVASCULAR AND METABOLISM
08/03/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $137.02 General
Category: Cardiology/Vascular Diseases
08/02/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $149.29 General
Category: Cardiology
07/17/2024 HEARTFLOW, INC. FFRct (Device) Consulting Fee Cash or cash equivalent $1,545.00 General
Category: Coronary
06/27/2024 HEARTFLOW, INC. FFRct (Device) Food and Beverage Cash or cash equivalent $110.94 General
Category: Coronary
05/09/2024 Amgen Inc. — Food and Beverage In-kind items and services $101.59 General
04/23/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $19.21 General
Category: Cardiology/Vascular Diseases
04/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $106.70 General
Category: Cardiology
04/06/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $76.28 General
Category: Cardiology
03/01/2024 HEARTFLOW, INC. FFRct (Device) Food and Beverage Cash or cash equivalent $8.50 General
Category: Coronary
01/29/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $123.92 General
Category: Diabetes Care
12/08/2023 Amgen Inc. — Food and Beverage In-kind items and services $37.48 General
12/07/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $59.69 General
12/07/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $48.41 General
Category: DIABETES
09/09/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $89.76 General
Category: Cardiology
07/21/2023 Amryt Pharma Holdings Ltd MYALEPT (Drug) Consulting Fee Cash or cash equivalent $4,230.00 General
Category: Endocrinology
05/18/2023 NOVARTIS PHARMACEUTICALS CORPORATION — Consulting Fee Cash or cash equivalent $600.00 General
02/09/2023 NOVARTIS PHARMACEUTICALS CORPORATION LEQVIO (Drug) Consulting Fee Cash or cash equivalent $4,869.00 General
Category: Cardiology/Vascular Diseases
11/05/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $111.11 General
Category: CARDIOVASCULAR
06/29/2022 Lilly USA, LLC TRULICITY (Drug), MOUNJARO Food and Beverage In-kind items and services $18.90 General
Category: Diabetes
1234»

Research Studies & Clinical Trials

Study Name Company Amount Records
PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH INCLISARIN RESEARCH Novartis Pharmaceuticals Corporation $8,750 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,451 1,752 $340,226 $80,667
2022 15 1,575 2,044 $374,223 $79,246
2021 16 1,526 1,995 $327,303 $107,025
2020 17 1,561 1,959 $314,182 $84,791
Total Patients
6,113
Total Services
7,750
Medicare Billing
$351,729
Procedure Codes
78

All Medicare Procedures & Services

78 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 374 475 $125,338 $25,435 20.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 262 262 $84,729 $11,570 13.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 39 39 $29,489 $10,960 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 93 106 $17,661 $6,952 39.4%
90662 Influenza vaccine split virus, preservative free Office 2023 62 62 $11,838 $4,449 37.6%
36415 Insertion of needle into vein for collection of blood sample Office 2023 234 420 $6,300 $3,528 56.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 24 24 $10,107 $3,465 34.3%
G0008 Administration of influenza virus vaccine Office 2023 65 65 $2,600 $2,083 80.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 17 17 $7,785 $1,921 24.7%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 29 29 $13,600 $1,863 13.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 45 $8,280 $1,858 22.4%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 17 17 $5,673 $1,641 28.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 13 13 $5,203 $1,635 31.4%
G0009 Administration of pneumococcal vaccine Office 2023 39 39 $1,560 $1,250 80.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $4,196 $1,088 25.9%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 46 46 $3,047 $472.54 15.5%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 38 38 $1,140 $212.48 18.6%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2023 30 30 $900.00 $185.92 20.7%
G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report Office 2023 13 13 $780.00 $96.40 12.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 460 701 $188,227 $32,366 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 93 102 $14,415 $6,950 48.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 143 143 $46,189 $6,157 13.3%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 17 17 $7,635 $4,744 62.1%
90662 Influenza vaccine split virus, preservative free Office 2022 67 67 $11,390 $4,592 40.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 90 90 $37,290 $3,118 8.4%
1234»

About Dr. Daniel Soffer, MD

Dr. Daniel Soffer, MD is a Internal Medicine healthcare provider based in Media, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205863198.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Soffer, MD has received a total of $61,441 in payments from pharmaceutical and medical device companies, with $10,665 received in 2024. These payments were reported across 85 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($41,743).

As a Medicare-enrolled provider, Soffer has provided services to 6,113 Medicare beneficiaries, totaling 7,750 services with total Medicare billing of $351,729. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Media, PA
  • Active Since 06/27/2006
  • Last Updated 09/09/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1205863198

Products in Payments

  • LEQVIO (Drug) $19,657
  • PRALUENT ALIROCUMAB INJECTION (Biological) $10,727
  • MYALEPT (Drug) $4,230
  • Repatha (Biological) $4,051
  • PRALUENT (Drug) $1,956
  • FFRct (Device) $1,698
  • ZYPITAMAG (pitavastatin) (Drug) $1,256
  • PRALUENT (Biological) $468.86
  • EVKEEZA (Biological) $356.54
  • JUXTAPID (Drug) $181.16
  • Cook Medical Peripheral Intervention (Device) $148.26
  • FREESTYLE LIBRE 3 (Device) $123.92
  • Vascepa (Drug) $120.87
  • ENTRESTO (Drug) $111.11
  • JARDIANCE (Drug) $48.41
  • Victoza (Drug) $39.00
  • ZOSTAVAX (Biological) $32.57
  • Prolia (Biological) $29.66
  • TRULICITY (Drug) $18.90
  • GENERAL VASCULAR INTERVENTION (Device) $16.20

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Media

Rajesh Patel, Md, MD

Internal Medicine — Payments: $116,429

Internal Medicine $116,429

George Lieb, Md, MD

Internal Medicine — Payments: $105,199

Internal Medicine $105,199

Benjamin Jacobs, Md, MD

Internal Medicine — Payments: $27,401

Internal Medicine $27,401

Leemu Kerkula, M.d, M.D

Internal Medicine — Payments: $11,422

Internal Medicine $11,422

Dr. Ezekiel Adewale, D.o, D.O

Internal Medicine — Payments: $11,030

Internal Medicine $11,030

Dr. Aaron Best, Do, DO

Internal Medicine — Payments: $8,431

Internal Medicine $8,431